MINAKEM in the news

Recent French Commercial Chamber rulings, including Subsonic and Minakem, clarify patent infringement litigation, emphasizing registration for standing to sue and the distinction between formal and real ownership.

Minakem's global employee count decreased by 20% from 603 in 2023 to 482 in 2026.

A French Supreme Court decision clarifies that a patent holder, even if knowing they aren't the true inventor, can sue for infringement until a claim of ownership by the true inventor is successful.

The French Supreme Court ruled that a patent holder's right to sue for infringement is independent of original patent ownership, reinforcing legal certainty and preventing procedural delays.

Minafin, a Belgian fine chemical group, has appointed Rudolph Hidalgo as CEO to lead its transformation and development in a challenging market, with founder Frédéric Gauchet shifting to strategy and board presidency.

A meeting following strikes at Minakem led to progress in negotiations between union representatives and management.

Minakem agreed on a social plan with 34 layoffs at its Beuvry-la-Forêt pharmaceutical manufacturing site after lengthy talks.

Minakem's Beuvry-la-Forêt site is undergoing layoffs affecting nearly half its staff, with strikes and ongoing negotiations supported by local officials.

Minakem is cutting 41 jobs at its Beuvry-la-Forêt pharmaceutical production site due to ongoing market challenges despite recent modernization efforts.

Minakem plans to lay off nearly half of its production staff at Beuvry-la-Forêt, prompting strikes and criticism from regional president Xavier Bertrand.

Minakem plans to lay off 41 production workers at its Beuvry-la-Forêt site, prompting strikes, while its R&D center remains unaffected.

Minakem's Beuvry-la-Forêt plant will cut nearly half its workforce due to economic pressures despite recent modernization investments.

Minakem employees in Dunkerque protested a cut in profit-sharing amid tough foreign competition in the chemical industry.

Minakem employees in Dunkerque strike over reduced bonuses and express concerns about site future and work conditions.

Workers at Minakem's Dunkerque site are striking today over reduced profit-sharing during a visit from the CEO.

Minakem's Beuvry-la-Forêt plant faces declining activity, prompting employee strikes demanding clear management commitments.

Olivier Ubrich becomes CEO of Minakem to drive growth and international expansion in pharmaceutical active ingredient synthesis and innovative therapies.

Minafin, through its Dunkerque site Minakem, has grown significantly by producing active pharmaceutical ingredients for major pharma clients and expanding into generics, with strong exports and increased production capacity.

Minafin acquired Delmar to establish a North American base with enhanced R&D and manufacturing capabilities for APIs.

Minakem expands into North America by acquiring Delmar from FIS, which was bought by Bain Capital, enhancing its pharmaceutical manufacturing and R&D capabilities.